Biosimilars and Demand Surge Shape Europe Adalimumab Market Landscape

bir ses eklendi Other

2026-03-27 06:41:32 -

"Executive Summary Europe Adalimumab Market Size and Share: Global Industry Snapshot CAGR Value Data Bridge Market Research analyses that the market is growing with a CAGR of 16.2% in the forecast period of 2022 to 2029 and is expected to reach USD 10,337.79 million by 2029 from USD 3,485.94 million in 2021. Each of the topics covered in the Europe Adalimumab report is studied...

0 Yorumlar 0 hisse senetleri 10 Views 0 önizleme